Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | 22.9x - 25.4x | 24.1x |
| Selected Fwd EBITDA Multiple | 15.5x - 17.1x | 16.3x |
| Fair Value | ﷼16.26 - ﷼18 | ﷼17.13 |
| Upside | -8.2% - 1.7% | -3.2% |
| Benchmarks | Ticker | Full Ticker |
| National Medical Care Company | 4005 | SASE:4005 |
| Naba Al Saha Medical Services Company | 9546 | SASE:9546 |
| Al Hammadi Holding Company | 4007 | SASE:4007 |
| Dr. Sulaiman Al Habib Medical Services Group Company | 4013 | SASE:4013 |
| Saudi Chemical Holding Company | 2230 | SASE:2230 |
| Twareat Medical Care Company | 9627 | SASE:9627 |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| 4005 | 9546 | 4007 | 4013 | 2230 | 9627 | ||
| SASE:4005 | SASE:9546 | SASE:4007 | SASE:4013 | SASE:2230 | SASE:9627 | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | 14.9% | NM- | 10.5% | 20.3% | 24.9% | NM- | |
| 3Y CAGR | 13.7% | 1.9% | 19.5% | 16.2% | 38.0% | NM- | |
| Latest Twelve Months | 16.5% | -33.3% | -3.4% | 21.8% | 2.6% | 57.4% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | 25.0% | 26.0% | 31.2% | 24.0% | 6.5% | 14.7% | |
| Prior Fiscal Year | 26.9% | 28.3% | 36.7% | 24.8% | 7.3% | 11.7% | |
| Latest Fiscal Year | 24.4% | 17.7% | 34.0% | 24.2% | 7.6% | 14.9% | |
| Latest Twelve Months | 25.1% | 17.7% | 31.4% | 23.8% | 7.4% | 14.9% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 5.14x | 3.54x | 4.40x | 7.43x | 1.15x | 3.75x | |
| EV / LTM EBITDA | 20.5x | 20.0x | 14.0x | 31.2x | 15.6x | 25.2x | |
| EV / LTM EBIT | 25.4x | 27.2x | 18.0x | 37.3x | 17.5x | 28.5x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | 14.0x | 20.0x | 31.2x | ||||
| Historical EV / LTM EBITDA | 25.2x | 25.2x | 25.2x | ||||
| Selected EV / LTM EBITDA | 22.9x | 24.1x | 25.4x | ||||
| (x) LTM EBITDA | 29 | 29 | 29 | ||||
| (=) Implied Enterprise Value | 655 | 689 | 724 | ||||
| (-) Non-shareholder Claims * | (11) | (11) | (11) | ||||
| (=) Equity Value | 643 | 678 | 712 | ||||
| (/) Shares Outstanding | 40.0 | 40.0 | 40.0 | ||||
| Implied Value Range | 16.09 | 16.95 | 17.81 | ||||
| FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 16.09 | 16.95 | 17.81 | 17.70 | |||
| Upside / (Downside) | -9.1% | -4.2% | 0.6% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4005 | 9546 | 4007 | 4013 | 2230 | 9627 | |
| Enterprise Value | 7,610 | 685 | 5,338 | 93,474 | 7,494 | 719 | |
| (+) Cash & Short Term Investments | 477 | 43 | 194 | 2,185 | 143 | 2 | |
| (+) Investments & Other | 0 | 2 | 147 | 473 | 0 | 0 | |
| (-) Debt | (454) | (89) | (287) | (9,034) | (1,722) | (13) | |
| (-) Other Liabilities | 0 | 0 | 0 | (472) | (13) | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 7,633 | 641 | 5,392 | 86,625 | 5,902 | 708 | |
| (/) Shares Outstanding | 44.7 | 10.5 | 160.0 | 350.0 | 843.2 | 40.0 | |
| Implied Stock Price | 170.80 | 61.00 | 33.70 | 247.50 | 7.00 | 17.70 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 170.80 | 61.00 | 33.70 | 247.50 | 7.00 | 17.70 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |